Works matching IS 00099236 AND DT 2022 AND VI 112 AND IP 2
Results: 28
Erratum.
- Published in:
- 2022
- Publication type:
- Correction Notice
Corrigendum: Abstracts of papers, 2022 Annual Meeting.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 412, doi. 10.1002/cpt.2692
- Publication type:
- Article
Diversity in Clinical Pharmacology Coming of Age.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 191, doi. 10.1002/cpt.2680
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 196, doi. 10.1002/cpt.2677
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 194, doi. 10.1002/cpt.2676
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 189, doi. 10.1002/cpt.2675
- Publication type:
- Article
Response to: Real‐World Data on the Risk of Ventricular Arrhythmias with Sulfonamides.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 203, doi. 10.1002/cpt.2669
- By:
- Publication type:
- Article
Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure Simulation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 353, doi. 10.1002/cpt.2649
- By:
- Publication type:
- Article
A Pharmacokinetics–Time to Alleviation of Symptoms Model to Support Extrapolation of Baloxavir Marboxil Clinical Efficacy in Different Ethnic Groups with Influenza A or B.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 372, doi. 10.1002/cpt.2648
- By:
- Publication type:
- Article
Polygenic Risk Scores for Blood Pressure to Assess the Risk of Severe Bevacizumab‐Induced Hypertension in Cancer Patients (Alliance).
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 364, doi. 10.1002/cpt.2635
- By:
- Publication type:
- Article
Opportunities and Challenges for Decentralized Clinical Trials: European Regulators' Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 344, doi. 10.1002/cpt.2628
- By:
- Publication type:
- Article
Presence of Five Chemotherapeutic Drugs in Breast Milk as a Guide for the Safe Use of Chemotherapy During Breastfeeding: Results From a Case Series.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 404, doi. 10.1002/cpt.2626
- By:
- Publication type:
- Article
Analysis of Patent and Regulatory Exclusivity for Novel Agents in China and the United States: A Cohort Study of Drugs Approved Between 2018 and 2021.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 335, doi. 10.1002/cpt.2625
- By:
- Publication type:
- Article
Contextualized Drug–Drug Interaction Management Improves Clinical Utility Compared With Basic Drug–Drug Interaction Management in Hospitalized Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 382, doi. 10.1002/cpt.2624
- By:
- Publication type:
- Article
Mobocertinib Dose Rationale in Patients with Metastatic NSCLC with EGFR Exon 20 Insertions: Exposure–Response Analyses of a Pivotal Phase I/II Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 327, doi. 10.1002/cpt.2622
- By:
- Publication type:
- Article
Model‐Based Prediction of Irinotecan‐Induced Grade 4 Neutropenia in Advanced Cancer Patients: Influence of Demographic and Clinical Factors.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 316, doi. 10.1002/cpt.2621
- By:
- Publication type:
- Article
Use of Real‐World Data and Physiologically‐Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 391, doi. 10.1002/cpt.2618
- By:
- Publication type:
- Article
Real‐World Data on the Risk of Ventricular Arrhythmias with Sulfonamides.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 201, doi. 10.1002/cpt.2617
- By:
- Publication type:
- Article
The Effect of Ibuprofen Exposure and Patient Characteristics on the Closure of the Patent Ductus Arteriosus in Preterm Infants.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 307, doi. 10.1002/cpt.2616
- By:
- Publication type:
- Article
Applying Modeling and Simulations for Rational Dose Selection of Novel Toll‐Like Receptor 7/8 Inhibitor Enpatoran for Indications of High Medical Need.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 297, doi. 10.1002/cpt.2606
- By:
- Publication type:
- Article
Physiologically‐Based Pharmacokinetic Modelling to Investigate Baricitinib and Tofacitinib Dosing Recommendations for COVID‐19 in Geriatrics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 291, doi. 10.1002/cpt.2600
- By:
- Publication type:
- Article
Roadmap to 2030 for Drug Evaluation in Older Adults.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 210, doi. 10.1002/cpt.2452
- By:
- Publication type:
- Article
Pharmacokinetic Drug Interactions of the New Oral Anticoagulants Revisited.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 208, doi. 10.1002/cpt.2447
- Publication type:
- Article
Clinical and Molecular Perspectives on Inflammation‐Mediated Regulation of Drug Metabolism and Transport.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 277, doi. 10.1002/cpt.2432
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, and Therapeutic Drug Monitoring of Valganciclovir and Ganciclovir in Transplantation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 233, doi. 10.1002/cpt.2431
- By:
- Publication type:
- Article
A Useful and Sustainable Role for N‐of‐1 Trials in the Healthcare Ecosystem.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 224, doi. 10.1002/cpt.2425
- By:
- Publication type:
- Article
Diversity and Inclusion in Drug Development: Rethinking Intrinsic and Extrinsic Factors with Patient Centricity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 204, doi. 10.1002/cpt.2416
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 181, doi. 10.1002/cpt.2299
- Publication type:
- Article